- 17/04/2026Contexto:A tuberculose (TB) continua sendo uma das principais causas de mortalidade por doenças infecciosas em todo o mundo. Embora o…
- 17/04/2026Background:Following a COVID-19 infection, approximately 65% of patients return to their previous health status within three weeks. However, about 10%…
- 17/04/2026Background:Genetic polymorphisms are known contributors to the risk of toxicity and the overall effectiveness of antitubercular therapy. Understanding these associations…
- 17/04/2026Background:Human T-cell lymphotropic virus type 1 (HTLV-1) is a significant public health concern in Brazil, known for establishing latent infections…
- 17/04/2026Background:Tuberculosis (TB) continues to cause significant morbidity and mortality globally, yet current diagnostic tools like interferon-gamma release assays (IGRAs) are…
- 17/04/2026Background:Approximately 95% of individuals infected with Mycobacterium tuberculosis do not progress to active tuberculosis (TB) disease. Identifying the specific determinants…
- 17/04/2026Background:Tuberculosis (TB) continues to be a leading cause of infectious disease mortality globally. Although Directly Observed Therapy (DOT) is widely…
- 17/04/2026Resumo: O surgimento e a rápida disseminação da variante Gama do SARS-CoV-2 no Brasil levantaram preocupações sobre a capacidade neutralizante…
- 17/04/2026Resumo:Métodos: Este estudo de implementação foi realizado no âmbito do consórcio RePORT-Brasil entre 2016 e 2019 em cinco centros de…
- 17/04/2026AbstractMethods: This implementation study was performed within the RePORT-Brazil consortium between 2016 and 2019 across five research centers. The study…